摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 67007-90-3

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
67007-90-3
化学式
C9H10N4O2S2*C42H70O35
mdl
——
分子量
1405.33
InChiKey
ZJYGVSFWBPKVLD-ZQOBQRRWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -14.0
  • 重原子数:
    94.0
  • 可旋转键数:
    10.0
  • 环数:
    23.0
  • sp3杂化的碳原子比例:
    0.84
  • 拓扑面积:
    652.02
  • 氢给体数:
    23.0
  • 氢受体数:
    41.0

反应信息

  • 作为产物:
    描述:
    磺胺甲噻二唑β-环糊精 为溶剂, 生成
    参考文献:
    名称:
    Spectral, thermal, and molecular modeling studies on the encapsulation of selected sulfonamide drugs in β-cyclodextrin nano-cavity
    摘要:
    In the present work the inclusion complexation of three sulfonamide (SA) drugs, namely sulfisoxazole (SSX), sulfamethizole (SMZ), and Sulfamethazine (STM) with beta-cyclodextrin (beta-CD) has been investigated using UV-Vis spectroscopy, DSC, H-1 NMR spectroscopy, and molecular modeling methods. The binding constant (K-b) of SA:beta-CD inclusion complexation was determined via applying the modified form of Benesi-Hildebrand equation employing the changes in absorbance at lambda(max). Obtained results revealed that SA drugs form 1:1 inclusion complex with beta-CD with K-b of 650, 1532, 714 M-1 at 25 degrees C for SSX, SMZ, and STM, respectively. The UV-Vis absorption spectra displayed solvatochromic behavior of bathochromic shift with decreasing solvent polarity that in turn is good agreement with their behavior in the presence of beta-CD in terms of environment polarity dependency. The inclusion complex formation between beta-CD and tested SA drugs in liquid and solid states was confirmed by 1H NMR and DSC, respectively. Using semi-empirical quantum chemistry methods at PM3 theoretical level, inclusion complexes' structures as well as energetic and thermodynamic parameters of encapsulation were elucidated. Obtained results revealed that the encapsulation is favorably energetic and enthalpic in nature with the inclusion of the aniline moiety through the wide rim side of beta-CD nano-cavity. Further, molecular modeling revealed that beta-CD encapsulation of SA drugs reduced their (E-HOMO - E-LUMO) gap. (C) 2014 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.saa.2014.04.136
点击查看最新优质反应信息